Wczytywanie kursów wyceny...
Prognoza
Nie mamy danych analityków dla tej spółki.
Wiadomości Przejdź do aktualności
Animalcare Group delisted from AIM after takeover by Charterhouse subsidiary
The shares of Animalcare Group were removed from trading on the AIM of the London Stock Exchange on Wednesday morning after CCP PAW 2 Limited — a 100% subsidiary of funds managed/advised by Charterhouse Capital Partners — acquired the company via a scheme of arrangement under Part 26 of the Companies Act 2006. The scheme took effect on Wednesday; Animalcare plans to convert into a private limited company. Financial and legal advisers on the transaction included Rothschild & Co, Stifel Nicolaus Europe, Panmure Liberum, Allen & Overy and Squire Patton Boggs. » Więcej na de.investing.com
Animalcare Group issues 967,954 new shares after option exercise
Following court approval of the takeover scheme and the exercise of outstanding options, Animalcare Group has issued 967,954 new ordinary shares. The exercise followed the takeover announcement by CCP PAW 2 Limited (Charterhouse) and rendered the options vested and exercisable under Rule 15 of the Takeover Code. The new shares are expected to be admitted to trading on AIM on Tuesday at around 08:00; issued share capital rises to 70,013,899 shares of 20 pence each. CEO Jennifer Winter received 468,797 shares (total 569,447; 0.81%) and CFO Christopher Brewster 188,384 shares (total 473,897; 0.68%). » Więcej na de.investing.com
JPMorgan increases stake in Animalcare Group to 6.356%
JPMorgan Chase & Co. has increased its voting stake in the Animalcare Group to 6.356% and now holds 4,388,686 voting rights. The position comprises 6.351% direct share voting rights via J.P. Morgan Securities PLC and 0.005% through cash-settled equity swaps with maturities to November 2026 and July 2027. The notification was made in accordance with UK disclosure requirements. » Więcej na de.investing.com
Historyczne dywidendy Dywidendy
Wszystkie wskaźniki dywidendowe Wszystkie wskaźnikiDane finansowe spółki
| (EUR) | grudzień 2025 | |
|---|---|---|
| Przychody | 51,98 mln | - |
| Zysk brutto | 25,51 mln | - |
| Zysk netto | 2,08 mln | - |
| EBITDA | 9,3 mln | - |
Dane fundamentalne
| Wskaźnik | Wartość |
|---|---|
Kapitalizacja rynkowa | 269,61 mln € |
Liczba akcji | 69,05 mln |
Maksimum/minimum z 52 tygodni | 3,96 € - 2,52 € |
Stopa dywidendy | 0,64% |
Dywidendy TTM | 0,0249 € |
Beta | 0,67 |
C/Z (PE Ratio) | 45,39 |
PEG (PEG Ratio) | -0,53 |
C/WK (PB Ratio) | 2,02 |
C/S (PS Ratio) | 2,60 |
Profil spółki
Animalcare Group plc entwickelt, verkauft und vertreibt zugelassene Tierarzneimittel und Identifizierungsprodukte sowie Dienstleistungen für Haus- und Nutztiere und für den Veterinärmarkt für Pferde. Darüber hinaus ist das Unternehmen im Großhandel und Vertrieb von Tierarzneimitteln tätig. Das Unternehmen beliefert Kunden in Belgien, den Niederlanden, dem Vereinigten Königreich, Deutschland, Spanien, Italien, Portugal, anderen europäischen Ländern, Asien, dem Nahen Osten, Afrika und international. Die Animalcare Group plc wurde 1972 gegründet und hat ihren Sitz in York, Vereinigtes Königreich.
| Nazwa | ANIMALCARE GROUP |
| CEO | Jennifer Ann Julia Winter |
| Siedziba | York,
ny Wielka Brytania |
| Strona internetowa | |
| Debiut giełdowy | 15.01.2008 |
| Pracownicy | 220 |
Deep Dive
Symbole giełdowe
| Giełda | Symbol |
|---|---|
London Stock Exchange | ANCR.L |
London | ANCR.L |
